Map each field
We combined secondary research with expert discussions to chart each space and spot openings.
A global pharmaceutical leader wanted opportunities to strengthen its oncology pipeline. We studied cancer vaccines, KRAS and liquid biopsies in turn, building a landscape for each and then testing hypotheses with experts.
The client is a global leader in the pharmaceutical industry with a strong oncology pipeline. It wanted opportunities that would add to that pipeline and could also stand on their own.
Prescouter was asked to explore opportunities that could enhance the client’s oncology pipeline or stand alone, focusing in turn on cancer vaccines, KRAS and liquid biopsies.
Early advances in vaccine design.
A closely watched oncology target.
Detecting cancer from a blood sample.
We combined secondary research with expert discussions to chart each space and spot openings.
We analyzed early-stage publications and technologies to see where innovation is moving.
More expert interviews and research answered the key questions in each topic area.
Prescouter analyzed 200 publications and early-stage technologies and identified the 6 most promising cancer vaccine platforms. The work also explored novel tertiary lymphoid structures, giving the client a clear view of early oncology innovation to guide pipeline decisions.
Publications and early-stage technologies.
The most promising in the field.
An emerging area worth watching.
Early science moves faster than pipelines. Mapping it field by field helps teams act before the opportunities get crowded.
Map the science, test the hypotheses and focus on the platforms that matter. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]Pick a time on our calendar right now.
If you’d like to know the outcome of your submission, please leave your email address